Board of Directors
-
Dr Hari Nair
Executive Chairman
Dr Nair has a PhD in Medicine and Clinical Science from the Australian National University with his specialty in cardiovascular medicine and haematology with a primary degree in Medicine and Physiology from the University of Aberdeen in Scotland. Dr Nair has received a number of awards from international organisations including being specially recognised for his role in coagulation research by the ACT government. He has run biotechnology companies in Australia and the US. Dr Nair has been heavily involved in mergers and acquisitions especially in the US and Europe and has US financial experience. Dr Nair’s corporate experience includes Financial raisings, corporate public relations and organisational integration strategies, Human Resources, IP strategy and management, financial management, Regulatory management and Research and Development. Dr Nair is an expert in Coagulation Science with a special emphasis on fibrinogen. Dr Nair is the author of over 100 research publications and has had over 50 patents on various aspects of the PrIME technology and its application in both plasma protein separations, renal dialysis and cellular separations. He discovered the use of nano carbon particles in the use of radiographic imaging of blood clots. Dr Nair has served on the boards of a number of international biotechnology companies and US state Commercialisation Boards for Georgia, Florida and Alabama. Dr Nair is a director of NuSep Ltd. -
John Manusu
Managing Director
Mr Manusu has over 20 years experience running biotechnology companies worldwide. Mr Manusu has been involved in the development of the PrIME technology since its invention in 1985 and its application to the therapeutic plasma market 10 years ago. Mr Manusu has undertaken a number of significant acquisitions and divestures, as well as raising over $100 million in public funding and government R&D grants. Mr Manusu has a degree in Commerce and is a Fellow of the Financial Services Institute of Australasia. Mr Manusu has worked in the Australia and U.S. Biotechnology markets and is best described as a biotechnology entrepreneur. Mr Manusu is a director of NuSep Ltd. -
Thee Woon Goh
Non-Executive Director
Mr Goh has over 30 years of leadership experience in large global organisations specialising in speciality chemicals, semiconductor manufacturing and electronic technologies. He has worked in Taiwan, Hong Kong, China, USA and Singapore. He brings with him wide ranging and in-depth corporate experience ranging from sales and marketing, business development, internal audit, quality systems development, customer relations management and human resources. He was intensively involved in the building up of new businesses in China as well as leading corporate restructuring and transformation, and post merger integration.
